sentences:  Chemotherapy-induced emesis is a major problem in cancer treatment.A new compound, T-2328 (figure 7), a non-peptide antagonist of the tachykinin NK1 family, is studied for that purpose.T-2328 is administered intravenously, and treats both acute and delayed emesis.